In 2025, medical device manufacturers are grappling with heightened regulatory uncertainty, leading to slower reviews and communication difficulties with the FDA. This situation drives them to reassess operations for compliance and risk management, with a strong emphasis on maintaining product quality, which is vital for patient safety.
Why it Pays to Prioritize Quality Amid Regulatory Uncertainty
Related Posts
DevSecOps with Agentic AI: Autonomous Security Testing in CI/CD Pipelines
Table of Contents AI Agents in DevOps and Security Strengthening Security in DevSecOps with Agentic AI How Does…
Will 2025 Be the Year You Invest in AI?
The 2025 landscape may shift significantly as more than half of companies plan to boost AI and automation…
Exact Metrology Announces New Partnership with Hexagon Manufacturing Intelligence
Partnership enhances product offerings to aerospace, automotive, defense, and manufacturing industries in the Midwest.